drugset / Trial / NCT04601324

Allergic Rhinitis Combination Pharmacotherapy Efficacy Study

NCT04601324

Phase 4 Withdrawn St. Paul's Sinus Centre
RandomizedParallel-groupSingle-blindTreatment

Summary

Combination pharmacotherapy is often used in people who have failed mono-therapies in managing their bothersome allergic rhinitis symptoms . However, there is a paucity of research indicating the most effective combination therapies in managing allergic rhinitis. This study aims to evaluate the efficacy of oral antihistamine (rupatadine) combined with nasal steroid (fluticasone propionate) compared to a well-studied combination therapy of nasal steroid with nasal antihistamine spray (MP-AzeFlu).

Timeline

Start
2020-12-15
Primary completion
2021-06-01
Completion
2021-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azelastine Small molecule 137 mg Intranasal
Subject Fluticasone propionate Other / unclassified 50 ug Intranasal
Subject Rupatadine Small molecule 10 mg Oral

Indications